secwatch.observer — SEC 8-K summary
======================================

Issuer:     TFF Pharmaceuticals, Inc. (—)
CIK:        0001733413
Form:       8-K
Filed at:   2024-07-01T23:59:59+00:00
Accession:  0001213900-24-057380
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

TFF Pharmaceuticals board member Michael Patane resigns effective June 30, 2024
-------------------------------------------------------------------------------

- Michael Patane resigned from the Board of Directors, effective June 30, 2024.
- No reason for the resignation was disclosed in the filing.
- No successor or replacement board member has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733413/000121390024057380/0001213900-24-057380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733413/000121390024057380/ea0208732-8k_tffpharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-057380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer